RECOMMENDED PATIENT-REPORTED CORE SET OF SYMPTOMS TO MEASURE IN PROSTATE CANCER TREATMENT TRIALS ArticleChen R.C., Stokes W.A., Reeve B.B., Chang P., Vetter R.J., Lukka H., Sanda M.G., Watkins-Bruner D., Sandler H.M.Journal of the National Cancer Institute. Том 106. 2014. dju132 с.
ASSOCIATIONS OF BREAST CANCER RISK FACTORS WITH TUMOR SUBTYPES: A POOLED ANALYSIS FROM THE BREAST CANCER ASSOCIATION CONSORTIUM STUDIES ArticleYang X.R., Chang-Claude J., Fischer H.P., Eccles D.M., Holland H., Dite G.S., Hopper J.L., Hammet F., Goode E.L., Lubiński J., Huzarski T., Hooning M.J., Kosma V.M., Couch F.J., Chenevix-Trench G., Apicella C., Nevanlinna H., Hamann U., Tapper W.J., Jakubowska A. ...Journal of the National Cancer Institute. Том 103. 2011. С. 250-263